ICL
NYSE · Chemicals
Icl Group Ltd
$5.15
+0.00 (+0.00%)
Financial Highlights (FY 2026)
Revenue
21.46B
Net Income
1.28B
Gross Margin
33.0%
Profit Margin
6.0%
Rev Growth
-0.6%
D/E Ratio
0.40
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 33.0% | 33.0% | 37.4% | 37.4% |
| Operating Margin | 11.3% | 10.2% | 17.6% | 17.0% |
| Profit Margin | 6.0% | 5.7% | 18.0% | 15.1% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 21.46B | 21.58B | 7.12B | 6.72B |
| Gross Profit | 7.08B | 7.12B | 2.66B | 2.51B |
| Operating Income | 2.43B | 2.20B | 1.25B | 1.14B |
| Net Income | 1.28B | 1.16B | 1.28B | 1.02B |
| Gross Margin | 33.0% | 33.0% | 37.4% | 37.4% |
| Operating Margin | 11.3% | 10.2% | 17.6% | 17.0% |
| Profit Margin | 6.0% | 5.7% | 18.0% | 15.1% |
| Rev Growth | -0.6% | -0.6% | +21.5% | +18.9% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 3.18B | 3.18B | 3.42B | 3.02B |
| Total Equity | 7.93B | 7.93B | 10.49B | 11.64B |
| D/E Ratio | 0.40 | 0.40 | 0.33 | 0.26 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 4.24B | 4.05B | 1.79B | 1.80B |
| Free Cash Flow | — | — | 781.09M | 495.76M |